Rhythm Biosciences Limited (ASX:RHY)
Australia · Delayed Price · Currency is AUD 0.2350
+0.0250 (11.90%)
Mar 18, 2026, 4:10 PM AEST
Rhythm Biosciences Market Cap
Rhythm Biosciences has a market cap or net worth of 77.13 million as of March 18, 2026. Its market cap has increased by 180.38% in one year.
Market Cap
77.13M
Enterprise Value
75.66M
Revenue
1.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.24
Market Cap Chart
Since December 7, 2017, Rhythm Biosciences's market cap has increased from 32.74M to 77.13M, an increase of 135.56%. That is a compound annual growth rate of 10.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 68.92M | 56.58% |
| Dec 31, 2025 | 44.02M | 78.41% |
| Dec 31, 2024 | 24.67M | -17.35% |
| Dec 29, 2023 | 29.85M | -86.11% |
| Dec 30, 2022 | 215.00M | -33.62% |
| Dec 31, 2021 | 323.86M | 83.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 856.40M |
| Healius | 417.53M |
| Australian Clinical Labs | 381.75M |
| Monash IVF Group | 245.47M |
| Cryosite | 58.33M |
| Microba Life Sciences | 48.72M |
| INOVIQ | 47.16M |
| BCAL Diagnostics | 36.87M |